Comments for Pharma's Cutting Edge http://www.pharmaweblog.com Pharmaceutical and biotech science and business Thu, 08 Oct 2009 02:37:20 +0000 http://wordpress.org/?v=2.6 http://www.feedburner.comhttp://www.feedburner.com/fb/images/pub/fb_pwrd.gifThis Feed Powered by FeedBurner.comThis is an XML content feed. It is intended to be viewed in a newsreader or syndicated to another site, subject to copyright and fair use. Comment on Active immunotherapy for prostate cancer: An update by Provenge success definitive now it seems | Pharma's Cutting Edge http://www.pharmaweblog.com/?p=284#comment-294 Provenge success definitive now it seems | Pharma's Cutting Edge Tue, 14 Apr 2009 20:11:41 +0000 http://pharmaweblog.com/blog/2007/05/09/provenge-setback/#comment-294
This is a content summary only. Visit my blog at http://www.pharmaweblog.com for full content, links and more!
]]> Comment on Reading Wyeth v Levine: Preemption narrowly interpreted by Wyeth v Levine #2: Implications for drug manufacturers | Pharma's Cutting Edge http://www.pharmaweblog.com/?p=654#comment-291 Wyeth v Levine #2: Implications for drug manufacturers | Pharma's Cutting Edge Fri, 06 Mar 2009 20:04:31 +0000 http://www.pharmaweblog.com/?p=654#comment-291
This is a content summary only. Visit my blog at http://www.pharmaweblog.com for full content, links and more!
]]> Comment on A simple reading of the Medtronic case decision by Reading Wyeth v Levine: Preemption narrowly interpreted | Pharma's Cutting Edge http://www.pharmaweblog.com/?p=344#comment-290 Reading Wyeth v Levine: Preemption narrowly interpreted | Pharma's Cutting Edge Thu, 05 Mar 2009 20:14:15 +0000 http://pharmaweblog.com/blog/2008/02/22/a-simple-reading-of-the-medtronic-case-decision/#comment-290
This is a content summary only. Visit my blog at http://www.pharmaweblog.com for full content, links and more!
]]>